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Terminal end budThe stromal microenvironment regulates mammary gland branching morphogenesis. We have observed that
mast cells are present in the mammary gland throughout its postnatal development and, in particular, are
found around the terminal end buds and ductal epithelium of the pubertal gland. Mast cells contribute to
allergy, inﬂammatory diseases, and cancer development but have not been implicated in normal
development. Genetic and pharmacological disruption of mast cell function in the mammary gland revealed
that mast cells are involved in rapid proliferation and normal duct branching during puberty, and this effect
is independent of macrophage recruitment, which also regulates mammary gland development. For mast
cells to exert their effects on normal morphogenesis required activation of their serine proteases and
degranulation. Our observations reveal a novel role for mast cells during normal pubertal development in the
mammary gland.
© 2009 Elsevier Inc. All rights reserved.Introduction
The developing mouse mammary gland is a good model for
investigating the mechanisms that regulate ductal epithelial growth
and invasion, in this case, into the mammary fat pad (Cunha et al.,
2000; Richert et al., 2000; Wiseman and Werb, 2002). At birth, the
mammary gland consists of a fat pad with a rudimentary ductal
epithelial tree descending into it from the overlying nipple. These
structures parallel the growth of the mouse until the start of puberty
(around 3 weeks of age), when ovarian hormones stimulate the
development of multilayered bulbous structures called terminal end
buds (TEBs) at the tips of growing and branching ducts (Richert et al.,
2000; Wiseman and Werb, 2002). Proliferation of TEB cells leads to
the bifurcation and elongation of duct structures towards the outer
edges of the fat pad by 10–12weeks of age, when the TEBs regress and
become terminal duct ends (Richert et al., 2000; Topper and Freeman,
1980). After the cycle of pregnancy, lactation, and involution, the
mammary gland returns to a state similar to that prior to pregnancy.
Although hormones are responsible for the initiation and
maintenance of TEB formation and duct elongation, a major inﬂuence
in mammary epithelial development is the mammary stroma.
Fibroblasts and adipocytes, blood vessels and bone marrow-derived
residentmacrophages and eosinophils and their products, growth and
survival factors, extracellular matrix proteins, and their degrading
proteases all contribute to mammary ductal development (Cunha and
Hom, 1996; Cunha et al., 2000; Gouon-Evans et al., 2000; Wisemanll rights reserved.and Werb, 2002). Proper epithelial growth requires coordination of
these diverse stromal components; therefore, the mammary fat pad is
a dynamic structure whose resident cells participate actively in the
process of mammary gland branching morphogenesis.
Mast cells are found in vascularized tissues, although they tend to
reside around blood vessels, nerves, epithelial cells, and smooth
muscle cells (Galli and Tsai, 2008; Kitamura, 1989; Metcalfe et al.,
1997). Mast cells are derived from hematopoietic progenitors in bone
marrow and circulate through the blood to tissues where they mature
into cells with a speciﬁc granule phenotype; the content of their
granules and/or phenotype differs depending on factors in their
destination's environment (Galli, 2000; Galli et al., 2005; Kitamura,
1989; Metcalfe et al., 1997).
Long known as potent effectors of the innate immune response,
mast cells ordinarily house and release factors capable of inﬂuencing
their extracellular environment (Metcalfe et al., 1997). Best known for
their role in releasing histamine, causing vasodilation and blood
vessel leakiness, mast cells also produce a host of serine proteases,
pro-inﬂammatory cytokines, pro-angiogenic factors such as vascular
endothelial growth factor (VEGF) and chemokines that contribute to
the metastatic potential of tumors (reviewed in Coussens and Werb,
2002; Metcalfe et al., 1997). Mast cells may secrete different
molecules selectively or in large amounts through the exocytic
process of degranulation (Galli and Tsai, 2008).
In our previous work, we showed that connective tissue-type mast
cells arepresent in themammary gland andare functionally involved in
mammary gland post-lactational involution through their binding of
plasma kallikrein (Lilla et al., 2009). These studies raise the possibility
that the presence and activity of mast cells may have numerous
consequences on the normal development and maintenance of
125J.N. Lilla, Z. Werb / Developmental Biology 337 (2010) 124–133mammary gland. In this study, we show that mast cells must play a
signiﬁcant role in normal mammary gland development during
puberty.
Materials and methods
Experimental animal models
Care of animals and animal experiments were performed in
accordance with protocols approved by the UCSF Institutional Animal
Use and Care Committee (IACUC). DPPI−/− mice (Pham and Ley,
1999) were provided by L. Coussens (UCSF). Wild-type FVB mice
were obtained from Charles River Laboratories. C57BL/6J-KitW-sh/W-sh
(W-sash) mice (Duttlinger et al., 1993) obtained from the Jackson
Laboratory and C57BL/6 mice obtained from Charles River Laborato-
ries (Wilmington, MA) were crossed to generate Kit+/W-sh offspring,
which were subsequently crossed to produce KitW-sh//W-sh, Kit+/W-sh,
and Kit+/+ siblings.
To stabilize mast cells from degranulating, CD1 female mice
(Charles River Laboratories) were injected intraperitoneally daily
from 3 to 5 weeks of age with 50 mg/kg body weight sodium
cromoglycate (Sigma, St. Louis, MO, USA) dissolved in saline as
previously described (Jamieson et al., 2005).
Estrus stage was determined for every mouse by vaginal smear
(Rugh, 1968) and onlymice in similar estrus phases were compared at
each time point.
Whole mount mammary gland preparation and morphometric analysis
For whole mount analysis, abdominal mammary glands were
removed at 3, 5, 8, and 12 weeks of age, spread on a glass slide, and
ﬁxed overnight in 75% ethanol, 25% glacial acetic acid. They were
then rehydrated and stained overnight at 4 °C in Alum Carmine stain
[2 g/l carmine dye (Sigma, St. Louis, MO, USA) and 5 g/l aluminum
potassium sulfate in distilled water]. The glands were then
dehydrated and immersed in Histoclear (Fisher Scientiﬁc) for lipid
removal and storage. Images were acquired using Nikon ACT-1
software on a Leica dissecting microscope and analyzed using Adobe
Photoshop and NIH Image (ImageJ) software. Duct lengths (in mm)
were measured from the nipple base to the tips of the 3 longest ducts
and averaged. The mammary gland invasion front was deﬁned by
epithelial structures that had extended past a bisecting line through
the lymph node perpendicular to the long axis of the abdominal
mammary fat pad. Numbers of terminal end buds and total numbers
of primary and secondary duct ends in the invasion front were
counted. Two-tailed Student's t-tests and one-way ANOVAs were
used to determine statistical signiﬁcance between groups (n=5 to
8 mice/group). Statistical signiﬁcance was considered when P≤0.05.
Histology, enzyme histochemistry, and immunoﬂuorescence
Contralateral abdominal mammary glands were removed at 3, 5, 8,
and 12 weeks of age and immediately embedded in OCT (Sakura)
medium on dry ice or were ﬁxed in 10% neutral-buffered formalin and
processed for parafﬁn embedding. 5 μm frozen or parafﬁn sections
were cut for use in histology, enzyme histochemistry, and immuno-
histochemistry. To visualize mast cells, frozen sections were air-dried
for≥30 minutes, post-ﬁxed in ice-cold acetone for 10 minutes, rinsed
in PBS, and then stained using an enzymatic reaction with naphthol
AS-D chloroacetate esterase (Sigma) to detect chymase activity
(Moloney et al., 1960), then counterstained with Gill's hematoxylin
or 4,6-diamidino-2-phenylindole (DAPI, Vector Laboratories, Burlin-
game, CA). Alternatively, parafﬁn sections were rehydrated and
stained with Toluidine blue [a metachromatic dye for mast cells,
made up of 0.1% Toluidine blue O (Sigma) in 1% sodium chloride, pH
2.3]. To examine collagen deposition and overall morphology of theglands, frozen sections were dried and ﬁxed with 10% neutral-
buffered formalin, then stained with 0.1% sirius red in saturated picric
acid (picro-sirius red) (Junqueira et al., 1979) and observed under
polarized light. Lipid content was determined by Oil Red O staining.
Frozen sections were ﬁxed for 1–2 days in 4% paraformaldehyde at
4 °C, rinsed in distilled water, air-dried for ≥90 minutes, then stained
in working Oil Red [3 parts saturated Oil Red O (Sigma, 0.5% in
isopropanol); 2 parts dextrin solution (1% type III corn dextrin
(Sigma) in distilled water)] for 20 minutes and counterstained with
Gill's hematoxylin (Sigma) and stored in PBS.
To identify macrophages and eosinophils in mammary glands,
frozen sections were stained for a macrophage cell surface glyco-
protein (Malorny et al., 1986) with rat anti-mouse F4/80 mAb
(Caltag Laboratories, Invitrogen, Carlsbad, CA), which also is found on
eosinophils (McGarry and Stewart, 1991). Slides were blocked in 4%
goat serum and 2% BSA (Sigma) in PBS, then incubated overnight
with 1:200 rat anti-mouse F4/80 at 4 °C followed by an Alexa 488-
conjugated goat anti-rat IgG (Molecular Probes, Invitrogen) with a
DAPI counterstain (Vector Laboratories, Burlingame, CA). For con-
trols, tissue sections were treated with an isotype-matched primary
antibody or by omission of the primary antibody. To identify mitotic
cells, frozen sections were blocked in 4% goat serum and 2% BSA
(Sigma) in PBS, then incubated overnight with a 1:500 dilution of
polyclonal anti-human phospho-histone H3 antibody (Ser10; Up-
state, Millipore, Billerica, MA) at 4 °C. Phospho-histone H3+ cells
were detected using an Alexa 594-conjugated goat anti-rabbit IgG
(Molecular Probes, Invitrogen) with a DAPI counterstain (Vector
Laboratories, Burlingame, CA). Controls were performed as described
above. Immunoﬂuorescence images were acquired at 200× using a
Leica DMR microscope and Leica FireCam with its accompanying
software. Quantiﬁcation of percentages of mitotic cells in mammary
ducts and TEBs was performed by excising duct or TEB structures from
images using Adobe Photoshop 7, counting the number of DAPI+ pixels
(blue), counting the number of phospho-histone H3+ pixels (red), and
expressing the ratio as a percentage of phospho-histoneH3+nuclei per
structure. A minimum of 10 images of ducts and TEBs apiece were
analyzed perW-sash phenotype at both 5 and 8weeks of age. One-way
ANOVAs were used to determine statistical signiﬁcance, which was
considered when P≤0.05.
Results
Mast cells are present in the stromal microenvironment of the mouse
mammary gland
Mast cells are present in pregnant, lactating, and involuting
mammary glands (Lilla et al., 2009; Russell et al., 2007; Szewczyk
et al., 2000). We ﬁrst analyzed the localization of mast cells during
mammary ductal morphogenesis. We identiﬁed a population of
histamine- and chymase-positive mast cells present in the developing
mammary gland. At 1 through 3 weeks of age, the prepubertal
mammary gland consists of a rudimentary epithelial tree near the
nipple at one end of a predominantly fatty stroma, consisting of
unilocular adipocytes, ﬁbroblasts, blood vessels, nerves, and a lymph
node, all surrounded by loose areolar connective tissue. In the
prepubertal gland, mast cells were scattered throughout the stromal
tissue, although in relatively small numbers, and did not appear to
localize to any particular structures (data not shown). By 5 weeks of
age, when the mammary gland begins to proliferate and grow in
response to ovarian hormones, the advancing ductal front is charac-
terized by the presence of TEBs. At 5weeks (Figs. 1A andB) and8weeks
(data not shown), mast cells were frequently observed in the stroma
immediately surrounding TEBs, adjacent to the periductal stroma or
just ahead of the advancing TEB. Mast cells were still scattered
throughout the mammary stroma, but more were found around the
more mature ducts (Figs. 1C and D) and blood vessels (Fig. 1E). At all
Fig. 1. Mast cells are present in the mammary stroma during postnatal development. (A–F) Formalin-ﬁxed, parafﬁn-embedded 5- μm sections of 5-week-old #4 mammary glands
stained with Toluidine blue, a metachromatic stain formast cell granules. Scale bar=50 μm. Red arrowheads indicate mast cells; black arrowheads specify mast cells shown in insets.
Insets are magniﬁed from original image 3.2 times. (A and B) Terminal end buds (TEB) with proximal mast cells. (C and D) Both stable (C) and degranulating (D) mast cells
surrounded more mature sections of the developing mammary ducts. (E) Mast cells were frequently observed adjacent to blood vessels (BV) in the mammary stroma. (F) Varying
numbers of mast cells were also located at the periphery of the resident lymph node (LN).
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lymph node (Fig. 1F). The presence ofmast cells throughoutmammary
gland development, and their increased number and proximity to the
growing ducts, led us to hypothesize that mast cells play a role in
normal mammary epithelial development.
Mast cells are required for normal pubertal mammary gland development
To test the hypothesis that mast cells are involved in pubertal
mammary gland development, we took a genetic approach using the
W-sash mast cell-deﬁcient mouse line (KitW-sh). This hypomorphic
mutation is the result of a spontaneous inversion mutation in the
regulatory region of the c-kit gene (Nagle et al., 1995), thus causing
a profound deﬁciency of mast cells in all tissues and signiﬁcant
deﬁcits in melanocytes without affecting other c-kit-dependent cell
types (Duttlinger et al., 1993; Grimbaldeston et al., 2005). In most
tissues, heterozygous Kit+/W-sh mice also have signiﬁcantly fewer
mast cells than wild-type littermates (Grimbaldeston et al., 2005),
providing a useful tool for examining the potential dosage effect of
mast cells under physiological conditions. By histology and enzyme
histochemistry, we veriﬁed that mast cells were completely absent
from the mammary glands of KitW-sh/W-sh mice but were present in
both Kit+/W-sh and wild-type littermates throughout development
(Fig. 2A and data not shown). The localization ofmast cells in Kit+/W-sh
and wild-type mice did not differ.We analyzed mammary gland morphogenesis in KitW-sh/W-sh,
Kit+/W-sh, and Kit+/+ mice at 3, 5, and 8 weeks of age by comparing
whole mounts of abdominal mammary glands for ductal outgrowth
(Figs. 2B and C). At 3 weeks, just before the onset of pubertal
development, the total number of primary and secondary duct ends
and TEBs did not differ by genotype. However, by 5 weeks of age, mast
cell-deﬁcient KitW-sh/W-sh mice had signiﬁcantly fewer duct ends in
the invasion front as well as fewer TEBs thanwild-type controls, while
Kit+/W-sh had an intermediate phenotype (Figs. 2D and E). The fewer
number of TEBs directly paralleled the reduced number of ducts. This
effect on duct end and TEB number persisted until 8 weeks of age,
when the advancing ducts terminated near the boundaries of the
mammary fat pad (Figs. 2D and E). Additionally, at both 5 and 8 weeks
of age, duct lengthswere reduced in KitW-sh/W-shmicewhen compared
to wild-type, and Kit+/W-sh had intermediate mean lengths, though
these observations did not reach statistical signiﬁcance (data not
shown). Observations of littermates at 12 weeks of age (n=2/
genotype) indicate that the developmental defects persisted in adult
virgin W-sashmutants and heterozygotes, with reduced duct lengths
and numbers of duct ends. However, as KitW-sh/W-sh and Kit+/W-sh are
capable of normal lactation and supporting average-sized litters, these
deﬁcits did not signiﬁcantly impair lactational mammary gland
function (data not shown).
These mast cell-dependent differences were not due to an overall
reduction in body growth or relativemammary fat pad sizes related to
Fig. 2. Mice lacking mast cells have defective mammary gland branching. (A) Mast cells are present in wild-type mammary gland but absent in W-sash mutant mice. Frozen 5-μm
sections of abdominal mammary glands from 5-week-old littermates stained with Toluidine blue. Red arrowheads indicate mast cells. Scale bar=100 μm. (B) Analysis of carmine-
stainedmammaryglandwholemounts required countingof TEBs (black arrowhead) andduct ends (gray arrowhead) past themid-lymphnode(denotedby line, LN=lymphnode). The
nipple is indicated by an asterisk. Scale bar=1 mm. (C) Comparison of carmine-stained whole mounts of left abdominal mammary glands fromW-sashwild-type, heterozygote, and
mutantmice at 3, 5, and8weeks of age. Scale bar=1mm.Theedgeofmammaryglandgrowth is outlinedbyawhite dotted line. (D) Counts of TEBs past themid-lymphnode fromwhole
mount analysis reveal that mast cell-deﬁcient mice have fewer TEBs in the pubertal mammary gland (n=8 mice/genotype/group; ANOVA values: ⁎5 weeks, P=0.038; ⁎⁎8 weeks,
P=0.024). (E)Counts of duct ends (primary andsecondarybranching) past themid-lymphnode fromwholemount analysis reveal thatmast cell-deﬁcientmicehave fewer duct ends in
the pubertal mammary gland (n=8 mice/genotype/group; ANOVA values: ⁎⁎⁎5 weeks, P=0.0003; ⁎8 weeks, P=0.0325). All error bars represent standard deviation.
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as the ratio of mammary gland weights to body weight, we found no
signiﬁcant differences between the different W-sash genotypes at any
of the ages analyzed (data not shown). Therefore, these data indicate
that the impairment in TEB formation and fewer ducts observed inW-
sashmutant and heterozygous as compared to wild-type mice are due
to mast cell deﬁciency and reduced mast cell numbers, respectively,
and point to a role for mast cells in normal postnatal mammary gland
development.
Mast cells in the mammary gland do not regulate macrophage
recruitment or collagen deposition around TEBs
Mast cells have been identiﬁed as key recruiters of leukocytes in
vivo (Gaboury et al., 1995; Kubes and Kanwar, 1994; Metz et al., 2007;Walsh et al., 1991). Thus, a possible mechanism for the function of
mast cells in mammary development might be to effect macrophage
recruitment (Chen et al., 2001). Moreover, macrophages regulate
mammary gland development, as macrophage-deﬁcient mammary
glands have delayed and reduced duct outgrowth (Gouon-Evans et al.,
2002; Gouon-Evans et al., 2000; Ingman et al., 2006). Macrophages
around TEBs during mammary development also play a role in
organizing the collagen-rich matrix surrounding the epithelial
structures (Ingman et al., 2006). We found that mast cell deﬁciency
in KitW-sh mutant mammary glands at 5 and 8 weeks of age did not
alter the presence of F4/80+ macrophage and eosinophils around
TEBs (Fig. 3A), as staining was similar in distribution and intensity in
mammary glands of heterozygote and Kitwild-type genotypes. These
results suggest that the W-sash mutant mammary developmental
defect was not due to a secondary loss of macrophages and/or
Fig. 3.Mast cell-deﬁcient mammary glands have normal macrophage recruitment and collagen deposition. (A) Immunoﬂuorescence on KitW-sh mutant, heterozygote, and Kitwild-
type mammary glands at 5 weeks of age using anti-F4/80 antibody with Alexa 488-conjugated secondary antibody (green), used to localize macrophages and eosinophils, DAPI
counterstain (blue), scale bar=100 μm. Arrowheads indicate areas of F4/80+ cells. (B) Picro-sirius red staining of mammary glands of mast cell-deﬁcient or mast cell-reduced mice
at 5 weeks of age to demonstrate by birefringence under polarized light the difference between thick (orange-yellow) and thin (green) collagen ﬁbrils around TEBs. Scale
bar=100 μm. Arrowheads indicate areas of collagen staining around the necks of TEBs.
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sirius red staining to observe birefringent ﬁbrillar collagen under
polarized light (Junqueira et al., 1979). At both 5 and 8 weeks of age,
we noticed no difference in collagen deposition by picro-sirius red
staining (Fig. 3B), or overall morphology of the TEBs and surrounding
stroma. These results suggest that the mast cell-dependent mammary
development phenotype is independent of macrophage-mediated
effects.
Mast cells are required for normal levels of proliferation in ducts and
TEBs in developing mammary glands
Mast cells are a rich source of growth factors. As mast cell
deﬁciency results in fewer duct ends and TEBs, we next determined
whether the mechanism underlying this effect was due to an altered
proliferative capacity of epithelial cells in the developing mammary
gland. We performed immunoﬂuorescence with an antibody against
the phosphorylated serine 10 residue of histone H3, a speciﬁc marker
for cells entering mitosis (Hendzel et al., 1997), to indicate prolifer-
ation in KitW-sh/W-sh, Kit+/W-sh, and Kit+/+ mice. We found fewer
mitotic cells in both ducts and TEBs of KitW-sh/W-sh mice than in wild-
type in 5- and 8-week-old mammary glands (Figs. 4A–C). Kit+/W-sh
mice had an intermediate percentage of mitotic duct and TEB cells,
consistent with their observed deﬁciency in TEB and duct ends
intermediate to that of the mast cell-deﬁcient mice and wild-type
controls. This decrease in proliferation was not accompanied by any
alteration in cell death or in the relative numbers of luminal and
myoepithelial cells (data not shown). Thus, these data indicate that
mast cells regulate TEB and duct cell proliferation during normal
pubertal mammary gland development.
Mast cell degranulation is necessary for normal mammary
gland development
Mast cell function generally is mediated by factors secreted from
mast cell granules. Conventionally activated mast cells either
degranulate and release a host of factors or they secrete speciﬁc
factors more selectively (Galli and Tsai, 2008; Metcalfe et al., 1997).Therefore, we asked whether the requirement for mast cells in
mammary gland development involves their degranulation to exert
their effects on ductal growth. We used sodium cromoglycate
(cromolyn sodium), which is thought to stabilize mast cells and
prevent degranulation by blocking the calcium ion inﬂux required to
trigger granule release from the cell (McIntyre et al., 1981).
We treated female CD1 outbred mice with cromolyn sodium
during the ﬁrst 2 weeks of pubertal development, from 3 to 5weeks of
age, when TEBs ﬁrst are formed and the mammary ductal tree
elongates from its prepubertal rudiment and begins to ﬁll the
mammary fat pad. Cromolyn sodium treatment signiﬁcantly inhibited
TEB formation and mammary duct end number (Figs. 5A–C). These
data indicate that degranulation is required for mast cells to exert
their effect on mammary duct growth. This suggests that during
mammary gland development, mast cells release granules that
contain some TEB growth-promoting mediator(s).
Serine protease activation is necessary for normal mammary
gland development
Proteases play an important role in mammary gland morpho-
genesis (Wiseman andWerb, 2002). Leukocytes are rich in precursors
of serine proteases, many of which are activated by dipeptidyl
peptidase I (DPPI), also known as cathepsin C. Mast cells have a
number of serine proteases concentrated in their granules. DPPI is the
in vivo activator of most mast cell granule serine proteases including
chymases and also acts as a regulator of the amount of active tryptase
(Wolters et al., 2001). These mast cell proteases mediate many of the
functions ascribed to mast cells in disease processes (Reed and Kita,
2004; Reid et al., 2007). To identify whether such serine proteases
inﬂuencemammary gland development, we used a geneticmodel that
allowed us to determine whether the activity of mast cell serine
proteases is involved. Mice deﬁcient for DPPI are healthy and fertile,
yet havemany inactivated proteases in granulocytic leukocytes (Pham
and Ley, 1999). We observed signiﬁcantly inhibited TEB and duct end
formation in mammary glands of mice that lacked DPPI compared to
controls at both 5 and 8weeks of age (Figs. 6A–C). These data suggest a
need for DPPI-dependent activation of mast cell granule proteases in
Fig. 4. Epithelial cell proliferation is reduced in TEBs and ducts in mast cell-deﬁcient mice. (A) Immunoﬂuorescence was performed on frozen sections of KitW-sh mutant,
heterozygote, and Kitwild-typemammary glands at 5 and 8weeks of age using an antibody against phospho-histone H3, a mitotic marker, and counterstained with DAPI. Shown are
a representative 5-week-old TEB and 8-week-old duct from Kitwild-type and KitW-sh/W-sh. Scale bar for each=100 μm. Phospho-histone H3+ nuclei were counted and expressed as
a percentage of mitotic cells per TEB or duct, respectively (n=8 mice/group). (B) Quantiﬁcation of mitotic epithelial cells in mast cell-deﬁcient mouse TEBs at 5 weeks (⁎ANOVA:
Pb0.0001). (C) Quantiﬁcation of mitotic epithelial cells in mast cell-deﬁcient mouse TEBs and ducts at 8 weeks (ANOVA values: ⁎5 weeks, P=0.0025; ⁎⁎8 weeks, P=0.0013). All
error bars represent standard deviation.
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mammary development. However, as DPPI also activates serine
proteases in other classes of leukocytes, the function of DPPI in
mammary gland development may not only involve mast cells.
Discussion
The stromal microenvironment is an essential partner in the
development of the mammary epithelial network during pubertal
development. In this study, we demonstrate a novel role for tissue
mast cells in the normal developmental process of branching
morphogenesis in the pubertal mammary gland. W-sash mice,
which have alterations in the c-kit promoter leading to profound
loss of mast cells in all tissues, provided us with a genetic model formast cell ablation in the mammary gland and revealed that mast cells
are necessary for proper TEB and duct formation. The numbers of mast
cells necessary for mammary development were critical, as W-sash
heterozygote glands, which have fewer mast cells than wild-type,
showed an impairment in development intermediate to that of the
mast cell-deﬁcient and wild-type glands. Furthermore, we found that
mammary gland mast cells must degranulate normally and have a
normal complement of active granule proteases. Previous work has
established that macrophages and eosinophils are necessary for
pubertal development of the mammary gland ductal epithelium. Our
study indicates that, along with macrophages and eosinophils
(Gouon-Evans et al., 2002, 2000), mast cells should be included in
the host of stromal cells that are necessary for pubertal development
of the mammary gland ductal epithelium (Fig. 7).
Fig. 5. Inhibition of mast cell degranulation blocked normal mammary gland branching. Mice were treated with cromolyn sodium, amast cell degranulation inhibitor, or control from
weeks 3 to 5 of age (n=7 mice/group). (A) Carmine-stained whole mounts of saline- and cromolyn sodium-treated mammary glands at 5 weeks. Scale bar=1 mm. The edge of
mammary gland growth is outlined in white. (B) Cromolyn sodium-treated mammary glands have fewer TEBs after 2 weeks of treatment (Student's t-test: ⁎⁎P=0.0047). (C)
Cromolyn sodium-treated mammary glands have fewer invading duct ends after 2 weeks of treatment (Student's t-test: ⁎P=0.049). All error bars represent standard deviation.
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and branching, and regulation of their cell proliferation and
differentiation, shape, and extracellular matrix is essential for proper
TEB formation and duct invasion into the mammary stroma. ReducedFig. 6.Mammary gland development is defective in mice lacking normal mast cell protease a
age were examined in whole mount preparations (n=6 mice/group). (A) Carmine-staine
bar=1 mm. The edge of mammary gland growth is outlined in white. (B) Mammary glands
(Student's t-test: ⁎5 weeks, Pb0.0001; ⁎⁎8 weeks, P=0.0013). (C) Mammary glands of DPP
(Student's t-test: ⁎5 weeks, P=0.0015; ⁎⁎8 weeks, P=0.0006). All error bars represent staTEB number and duct branching have been reported in many mouse
models, implicating hormones, cytokines, extracellular matrix pro-
teins and their receptors and proteases, and growth and transcription
factors in this morphogenetic process (for review, see Howlin et al.,ctivation. Mammary glands of DPPI−/−mice and wild-type controls at 5 and 8 weeks of
d whole mounts of wild-type and DPPI−/− mammary glands at 5 and 8 weeks. Scale
of DPPI−/−mice have fewer TEBs than wild-type controls at both 5 and 8 weeks of age
I−/− mice have fewer duct ends than wild-type controls at both 5 and 8 weeks of age
ndard deviation.
Fig. 7. Diagram of innate immune cells that contribute to the stromal effects on mammary gland branching morphogenesis. (A) The diagram depicts the stromal locations of
eosinophils, macrophages, and mast cells relative to a terminal end bud (TEB). The TEB consists of a single layer of cap cells and multiple layers of body cells, which will eventually
make up the luminal cells of the mature duct surrounded by a myoepithelial layer. The area surrounding the neck of the TEB consists of a collagen-rich stroma including ﬁbroblasts,
macrophages, and eosinophils. At the invading edge of the TEB, a thin basement membrane separates the advancing TEB from the adipocyte-rich stroma. Mast cells are found around
the TEB in the stromal compartment, often just ahead of the advancing epithelium. (B) Depiction of the effect of mast cell activation on mammary gland development. Mast cell
degranulation and subsequent release of active proteases stimulate epithelial cell proliferation, promoting TEB formation and duct branching in the pubertal gland.
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sis in the TEBs allows them to invade the adipocyte- and ﬁbroblast-
rich stroma, resulting in duct elongation, as well as allows the TEB to
bifurcate, resulting in ductal branching (Richert et al., 2000). While
mast cells are found throughout the mammary stroma, they are also
concentrated around the invading TEBs ahead of and beside the
advancing end buds. The proximity of mast cells near TEBs during
pubertal development, taken together with our observations that
mammary glands without or with fewer mast cells had a lower
percentage of proliferating cells in both TEBs and ducts during this
period, suggests that mast cells contribute to the complex regulation
of cell proliferation in the growing mammary gland.
How might mast cells mediate this regulation of proliferation?
First, mast cells might recruit other cells known to affect mammary
development; second, mast cells might alter the stromal ECM
immediately surrounding the invading ducts where they reside; or
third, mast cell-derived mediators could regulate mitogens that affect
mammary epithelial cells. Although mast cells can recruit leukocytes
to tissues in vivo (Chen et al., 2001; Gaboury et al., 1995; Kubes and
Kanwar, 1994; Walsh et al., 1991), we ruled out the possibility that
the effects of mast cells were solely due to their recruitment of
macrophages and/or eosinophils, which also regulate mammary
gland development (Gouon-Evans et al., 2000), to the developing
mammary gland. Moreover, we observed that mast cell loss had no
effect on collagen deposition around TEBs, as has been reported for
macrophage loss (Ingman et al., 2006). However, our results do not
exclude other relationships between inﬂammatory cells or stromal
matrix proteins and mast cells and their products in mammary gland
development.
Resident mast cells in the mammary gland may arise from pre-
cursors recruited to the mammary stroma proper where they mature
locally or maymigrate asmature cells to themammary gland from the
surrounding subdermal connective tissue. Given their role in
leukocyte recruitment, it is not clear whether the mast cells localizedto the mammary lymph nodes have the same function as the mast
cells found throughout the rest of the mammary fat pad, especially
those that are found around the developing gland. Interestingly, a
genetic model for eosinophil overabundance through transgenic
overexpression of interleukin-5 also results in reduced TEB and duct
formation (Sferruzzi-Perri et al., 2003), suggesting that leukocyte
recruitment and regulation must be ﬁnely controlled to promote
mammary duct development.
The W-sash model revealed a role for stromal mast cells during
mammary gland development.We further determined thatmammary
mast cells must be able to degranulate, and the granules must have
active and normal levels of proteases within those granules to exert
their effects on mammary gland development. As mast cell granules
contain histamine, proteoglycans, growth factors, and many pro-
teases including serine proteases such as chymases and tryptases
(Galli and Tsai, 2008; Metcalfe et al., 1997), there are many granule
components that potentially could contribute to regulation of
mammary gland development. Of these, mast cell proteases are
candidates for the mechanism by which mast cells affect the
developing mammary gland.
Ideally, the reconstitution of mast cells into the W-sash mice
should revert the mast cell deﬁciency phenotype. Unfortunately, mast
cells derived from bone marrow culture injected directly into the
glands require at least 8 weeks post-injection to fully engraft (J. Lilla,
unpublished observations). Since the onset of mammary pubertal
development occurs at 3 weeks of age, with the greatest difference in
phenotype observed at 5 weeks of age, we were not able to rescue the
W-sash phenotype by engraftment of C57BL/6 Kit+/+ β-actin–CFP
bone marrow cells into KitW-sh/W-sh animals due to the long lag period
before mast cell reconstitution in the mammary gland, as has been
observed in other tissues previously (Grimbaldeston et al., 2005).
Given the technical challenges in achieving a timely engraftment
of mast cells to the pubertal mammary gland, we analyzed other non-
kit-dependent mast cell-altered animals to conﬁrm our ﬁndings.
132 J.N. Lilla, Z. Werb / Developmental Biology 337 (2010) 124–133Further evidence supporting speciﬁc roles for mast cell granule com-
ponents was obtainedwith cromolyn sodium treatment, showing that
mast cell degranulation was necessary for the manifestation of mast
cell function in mammary development.
Tissue-type mast cell proteases have been implicated in angio-
genesis (Blair et al., 1997; Coussens et al., 1999) and extracellular
matrix protein degradation either directly (Vartio et al., 1981;
Wolters et al., 2000) or by activation of other ECM proteases
(Johnson et al., 1998). Our data show an impairment in the mammary
gland development of mice with reduced mast cell protease activity
(DPPI−/− mice), implicating these proteases in mammary develop-
ment. Aside from its function in normal tryptase expression and
chymase activation in mast cells (Wolters et al., 2001), DPPI/
cathepsin C has proteolytic activity towards ECM proteins such as
ﬁbronectin and collagens I and IV (Wolters et al., 2000). Thus, DPPI
activity could account for the mammary gland phenotype reported
here, either directly or through its activation of tryptase and chymase,
which in turn might act directly or as activators of yet other proteases
such as matrix metalloproteinases. Interestingly, our preliminary
analysis of mMCP4 (mouse mast cell protease 4/mouse chymase)-
deﬁcient mice at 5 weeks of age did not suggest a role for chymase in
mammary development (data not shown). It is important to note that
DPPI is also required for normal processing and activation of
neutrophil serine proteases (Adkison et al., 2002), so the DPPI−/−
mammary phenotype may not reﬂect solely a requirement for normal
mast cell protease activity.
Our study implicates mast cell proteases as likely effectors of mast
cell activity on the developing mammary gland; however, other mast
cell mediators could also be involved in a protease-dependent
pathway. The major effect of mast cells was to regulate mammary
epithelial proliferation. Thus, mast cell-derived growth factors,
chemokines, cytokines, or lipid-derived mediators could also contrib-
ute to the effects onmammary gland development. Mast cells regulate
angiogenesis through multiple pathways, including by direct release
of vascular endothelial growth factor (VEGF) (Heissig et al., 2005) and
indirectly by releasing ECM proteases that remodel the stroma to
encourage angiogenesis (Levi-Schaffer and Pe'er, 2001). Although
VEGF and VEGF receptor expression is high in the stroma of pubertal
mammary glands (Hovey et al., 2001), our preliminary observations
of the vasculature of W-sash mammary glands at 5 weeks of age did
not reveal any discernable differences between mast cell-deﬁcient,
reduced, or wild-type animals (data not shown).
Expression of histamine and some of its receptors changes signi-
ﬁcantly during the estrus cycle and is highly expressed by mammary
alveolar epithelium during pregnancy and lactation (Maslinski et al.,
1993; Wagner et al., 2003). Mice null for histidine decarboxylase, the
major enzyme responsible for histamine synthesis, are fertile, yet have
reduced numbers of tissue mast cells, which also have reduced
granular content (Ohtsu et al., 2001). Whether the null mammary
glands have a mammary gland developmental phenotype remains to
be studied. Two other intriguing candidates for the effect of mast cells
on mammary gland development are transforming growth factor-β
(TGF-β) and prostaglandin D2. However, as TGF-β and prostaglandin
D2 inhibit mammary epithelial proliferation (Silberstein et al., 1992;
Yee et al., 2003), it is unlikely that loss of these mast cell mediators
would account for the negative effects on mammary development we
observed in our study.
Taken together, our results indicate that mast cells function in a
developmental process, in addition to their well-studied functions in
innate immune responses. Mast cells must be present, be capable of
normal degranulation, and have activated granule-associated pro-
teases to facilitate normal mammary gland pubertal development in
the mouse. Their location near the advancing ducts throughout
pubertal morphogenesis places them in an ideal position to promote
cell proliferation during TEB formation and duct branching in the
growing mammary gland.Acknowledgments
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